Search

everythinglearnresearchcommunity

for

Search:↓

A girl with Denys-Drash syndrome was misdiagnosed due to biotin affecting her hormone test results.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Male hormones worsen kidney transplant damage, but blocking them helps.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

The document concludes that accurate diagnosis and management of PCOS are crucial due to its associated health risks.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Leydig cells can cause testosterone-secreting adrenal tumors in women.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

The triterpenoids from Ganoderma lucidum can block testosterone effects and may help treat enlarged prostate.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.